528
Views
5
CrossRef citations to date
0
Altmetric
Articles

Central nervous system involvement by mantle cell lymphoma

ORCID Icon, , ORCID Icon, , , , ORCID Icon, ORCID Icon, , , , , , & ORCID Icon show all
Pages 371-377 | Received 21 Jul 2022, Accepted 29 Oct 2022, Published online: 23 Nov 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Anath C. Lionel, Ashwath Gurumurthi, Ahmed Fetooh, Rami Eldaya, Sairah Ahmed, Swaminathan P. Iyer, Loretta J. Nastoupil, Jason Westin, Ranjit Nair, Luis Fayad, Luis Malpica, Sudhakar Tummala, Christopher Flowers, Sattva S. Neelapu, Michael L. Wang & Preetesh Jain. (2024) Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement. Leukemia & Lymphoma 65:5, pages 669-673.
Read now
Chiara Rusconi & Carlo Visco. (2023) Putting the brain into mantle cell lymphoma. Leukemia & Lymphoma 64:2, pages 259-260.
Read now

Articles from other publishers (2)

Katharine L. Lewis & Chan Y. Cheah. (2023) Chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with central nervous system involvement: Progress, but not perfect. British Journal of Haematology 203:5, pages 701-703.
Crossref
Juan Pablo Alderuccio, Lakshmi Nayak & Kate Cwynarski. (2023) How I treat secondary CNS involvement by aggressive lymphomas. Blood 142:21, pages 1771-1783.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.